FDA Inspection 1162837 - The Procter & Gamble Manufacturing Company - February 18, 2022

Record Details

This FDA Inspection record concerns The Procter & Gamble Manufacturing Company, with an inspection on February 18, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: The Procter & Gamble Manufacturing Company
Inspection Date: February 18, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · daa97680-4c92-4913-802a-c70e906cb036

Violation Codes3

21 CFR 211.110(a)21 CFR 211.19221 CFR 211.67(b)

Full citation text and observation details available on the Dashboard.